Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

Rheumatoid arthritis is one of the most common immune-mediated diseases. Its primary manifestation is inflammatory arthritis characterized by symmetric, polyarticular pain and swelling, typically ...

RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking preclinical research that supports a nearly ...

GLP-1RAs were associated with lower risks for major adverse cardiac events, including heart failure, among patients with ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...